Khalid Arshad, MD
Child & Adolescent Psychiatry · Kankakee, ILNPI 1306259817
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 404 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. Among child & adolescent psychiatry clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 404 payments — averaging $19.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- Neurocrine Biosciences, Inc.$674
- Indivior Inc.$572
- Teva Pharmaceuticals USA, Inc.$555
- Supernus Pharmaceuticals, Inc.$551
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$542
- plus $4K from 24 others
What the payments were for
- Food & beverage$7,855100%
- Education$270%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 70 | $1,267 |
| Neurocrine Biosciences, Inc. | 30 | $674 |
| Indivior Inc. | 23 | $572 |
| Teva Pharmaceuticals USA, Inc. | 37 | $555 |
| Supernus Pharmaceuticals, Inc. | 26 | $551 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 30 | $542 |
| Alkermes, Inc. | 24 | $478 |
| AbbVie | 14 | $379 |
| Ironshore Pharmaceuticals Inc. | 18 | $376 |
| Johnson & Johnson | 18 | $337 |
| Axsome Therapeutics, Inc. | 12 | $289 |
| Corium, LLC | 12 | $273 |
| Lundbeck LLC | 13 | $264 |
| Tris Pharma Inc | 14 | $259 |
| Almatica Pharma LLC | 14 | $242 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $214 |
| Vanda Pharmaceuticals Inc. | 5 | $90 |
| Biogen | 4 | $72 |
| Sunovion Pharmaceuticals Inc. | 3 | $64 |
| Idorsia Pharmaceuticals US Inc | 4 | $58 |
| Merck | 3 | $55 |
| Neos Therapeutics, LP | 3 | $54 |
| Shire North American Group Inc | 4 | $54 |
| E.r. Squibb & Sons, L.L.C. | 2 | $51 |
| Luye Pharma (USA) Ltd. | 2 | $46 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| GSK | 1 | $14 |
| Acadia Pharmaceuticals Inc | 1 | $12 |
| Eisai Inc. | 1 | $12 |
How this compares
$7,883 in reported general payments places this provider in the 95th percentile of 124 child & adolescent psychiatry providers in Illinois.
See all child & adolescent psychiatry providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 19 | $2,182 |
| Quetiapine Fumarate | 22 | $698 |
| Bupropion XlBupropion Hcl | 15 | $541 |
| Fluoxetine Hcl | 14 | $397 |
| Trazodone Hcl | 30 | $372 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 16 | $317 |
| Risperidone | 20 | $305 |
| Duloxetine Hcl | 15 | $237 |
| Escitalopram Oxalate | 15 | $168 |
| Lorazepam | 12 | $89 |
| Alprazolam | 14 | $80 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Kankakee
- Fareha MalikElgin$57K
- Gregory TeasHoffman Estates$36K
- Martins AdeoyeOrland Park$10K
- Daniel MartinezLombard$8K
- Talat GhausHinsdale$6K
- Walter PedemonteOak Park$5K
- Shazia TayyabLibertyville$5K
- Bradley PechterMelrose Park$5K
- Birju PatelKenilworth$5K
- Ing LamOrland Park$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.